Autoimmune diseases and vaccinations

European Journal of Dermatology

Volumn 14, Issue 2, 2004, Pages 86-90

  Vial, Thierry ^a   Descotes, Jacques ^a  

^a Centre de Pharmacovigilance   (France)

Author keywords

Autoimmunity; Drug surveillance; Epidemiology; Safety; Vaccine

Indexed keywords

BCG VACCINE; DIPHTHERIA TETANUS TOXOID; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; DEMYELINATING DISEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGICAL DATA; GUILLAIN BARRE SYNDROME; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; GUILLAIN-BARRE SYNDROME; HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; VACCINES;

EID: 1942473044     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 362: 1659-66.
2. Chen RT, Pless R, DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001; 16: 309-18.
3. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Pragram, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-23.
4. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-802.
5. Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome. Clin Immunol 2003; 107: 116-21.
6. Seyal M, Ziegler DK, Couch JR. Recurrent Guillain-Barre syndrome following influenza vaccine. Neurology 1978; 28: 725-6.
7. Wijdicks EF, Fletcher DD, Lawn ND. Influenza vaccine and the risk of relapse of Guillain-Barre syndrome. Neurology 2000; 55: 452-3.
8. Pritchard J, Mukherjee R, Hughes RA. Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurq Psychiatry 2002; 73: 348-9.
9. Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991; 338: 1174-5.
10. Gout O, Lyon-Caen O. Sclerotic plaques and vaccination against hepatitis B. Rev Neurol 1998; 154: 205-7.
11. Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327-32.
12. DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504-9.
13. Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, Shinefield H, Chen RT, Ellenberg SS. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol 1998; 51: 503-10.
14. Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 2000; 355: 549-50.
15. Touze E, Fourrier A, Rue-Fenouche C, Rande-Oustau V, Jeantaud I, Begaud B, Alperovitch A. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology2002; 21: 180-6.
16. Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5: 964-5.
17. DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk at multiple sclerosis. Expert Rev Vaccines 2002; 1: 461-6.
18. Levy-Bruhl D, Desenclas JC, Rebiere I, Drucker J. Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France. Vaccine 2002; 20: 2065-71.
19. Hernan MA, Jick SS, Olek MJ, Ascheria A, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Pharmacoepidemiology Drug Saf 2003; 12(suppl. 1): 59-60.
20. Hiltunen M, Lännrat M, Hyöty H. Immunisation and type 1 diabetes mellitus. Is there a link? Drug Safety 1999; 20: 207-2.
21. Singh B. Stimulation of the developing immune system can prevent autoimmunity. J Autoimmun 2000; 14: 15-22.
22. Classen DC, Classen JB. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infect Dis Clin Pract 1997; 6: 449-54.
23. Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996; 24: 137-45.
24. Ravel G, Christ M, Liberge P, Burnett R, Descotes J. Effects of two pediatric vaccines on autoimmune diabetes in NOD female mice. Toxicol Lett 2003; 146: 93-100.
25. Heijbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 1997; 20: 173-5.
26. Dahlquist G, Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 1995; 38: 873-4.
27. Parent ME, Siemiatycki J, Menzies R, Fritschi L, Colle E. Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997; 20: 767-72.
28. Blam L, Nystrom L, Dahlquist G. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetalogia 1991; 34: 176-81.
29. DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001; 108: E112.
30. Graves PM, Barriga KJ, Norris JM, Hoffman MR, Yu L, Eisenbarth GS, Rewers M. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 1999; 22: 1694-7.
31. Karvonen M, Cepaitis Z, Tuomilehto J. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. Br Med J 1999; 318: 1169-72.
32. Classen JB, Classen DC. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity 2002; 35: 247-53.
33. Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, DeStefano F, Chen R. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J 2002; 21: 568-9.
34. Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J; Abis Study Group. Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Ann N Y Acad Sci 2003; 1005: 404-8.
35. Aron-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001; 10: 237-40.
36. Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998; 25: 1687-93.
37. Older SA, Battafarano DF, Enzenauer RJ, Krieg AM. Can immunization precipitate connective tissue disease? Semin Arthritis Rheum 1999; 29: 131-9.
38. Sturkenbbom MC, Fautrel B, Razenberg S, Bégaud B, Roullet E, Heinzlef O. Vaccinations against hepatitis B and lupus erythematasus. Pharmacoepidemiol Drug Safety 2000; 9 (suppl. 1): S71.
39. Sturkenbbom MC, Fautrel B, Rozenberg S, Bégaud B, Roullet E, Heinzlef O. Vaccinations against hepatitis B and rheumatoid arthritis. Pharmacoepidemiol Drug Safety 2000; 9 (suppl. 1): S71.
40. Miller AE, Margante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La Rocca N, Lopez S. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997; 48: 312-4.
41. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 2001; 344: 319-26.
42. Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A. Immunization af patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994; 21: 1203-6.
43. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with systemic lupus erythematasus: effects an disease activity. J Rheumatol 2000; 27: 1681-5.
44. Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, Hoyt A, Lima J, Goadman D, Lieberman M, Enzenauer RJ. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41: 1828-34.
45. Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis 8 in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 623-5.
46. Descotes J, Ravel G, Ruat C. Vaccines: predicting the risk of allergy and autoimmunity. Toxicology 2002; 174: 45-51.
47. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001; 108: 1097-104.
48. Fournie GJ, Mas M, Cautain B, Savignac M, Subra JF, Pelletier L, Saoudi A, Lagrange D, Calise M, Druet P. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 2001; 16: 319-26.
49. Havarinasab S, Lambertsson L, Qvarnström J, Hultman P. Dose-response study of thimerosal induced murine systemic autoimmunity. Toxicol Appl Pharmacol 2004; 194: 169-179.
50. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001; 2: 797-801.
51. Classen JB, Classen DC. Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action. Med Hypotheses 2001; 57: 532-8.
52. Shoenfeld Y, Aron-Maor. Vaccination and autoimmunity - 'Vaccinosis': a dangerous liaison? J Autoimmun 2000; 14: 1-10.
53. Vial T, Choquet-Kastylevsky G, Descates J. Adverse effects of immunotherapeutics involving the immune system. Toxicoloqy 2002; 174: 3-11.
54. Silveira PA, Baxter AG. The NOD mouse as a model of SLE. Autoimmunity 2001; 34: 53-64.
55. Ravel G, Christ M, Horand F, Descotes J. Autoimmunity, Environmental exposure and Vaccination: Is there a link? Toxicology 2004; in press.